BMO Capital resumed coverage of Affirm (AFRM) with an Outperform rating and $69 price target The shares are down over 40% from recent highs as ...

BMO Capital Markets’ price target points to a potential upside of 21.99% from the company’s current price. A number of other research firms have also issued reports on DT.

Shares of Algoma Central stock opened at C$14.98 on Monday. Algoma Central has a one year low of C$14.03 and a one year high of C$15.60. The firm has a market capitalization of C$613.30 million, a ...

Short sellers have made big profits so far in 2025 as some of the market’s biggest stocks have dropped. According to S3 Partners, betting against Tesla and Nvidia has earned sho ...

BMO Capital keeps an Outperform rating and $495 price target on Adobe (ADBE) after the company’s analyst event presentation that was focused on ...

According to BMO's analysis, Cenovus Energy, Spartan Delta, and Kelt Exploration saw the highest levels of total insider ...

Taylor Swift wrapped up her monumental Eras Tour last year, but Nvidia is on one of its own, according to BMO Capital Markets analyst Brian Pitz. "We are entering the era of general physical AI," he ...

BMO Capital Markets initiated coverage on Dyne Therapeutics (DYN, Financials) with an Outperform rating and a $50 price target, suggesting a strong upside from the company's current share price of ...